Spices and dietary supplements with anti-inflammatory activity

Immunonutrition: Interactions of Diet, Genetics, and Inflammation

Volumn , Issue , 2014, Pages 317-331

  Aggarwal, Bharat B ^a   Heber, David ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84961605567     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b16661     Document Type: Chapter

References (95)

1. USC-UCLA Joint East Asian Studies Center. 1993. Along the silk road, people, interaction & cultural exchange. http://www.ess.uci.edu/~oliver/silk3.html (accessed on November 7, 2013).
2. Silk Road Study Group. 2000. Silk road. http://gallery.sjsu.edu/silkroad/intro.htm (accessed on November 7, 2013).
3. Parry JW. 1953. The Story of Spices. New York: Chemical Publishing Co.
4. McCormick Science Institute. 2008. The history of spices. http://www.mccormicksciencein stitute.com/Spice-Landing/History-of-Spices.aspx (accessed on July 17, 2013).
5. Ali SS, Kasoju N, Luthra A et al. 2008. Indian medicinal herbs as sources of antioxidants. Food Intern. J. 41:1-15.
6. Blumenthal M. 1998. The Complete German Commission E Monographs, Therapeutic Guide to Herbal Medicines. Austin, TX: American Botanical Council.
7. Frishman HW, Sinatra TS, Moizuddin M. 2004. The use of herbs for treating cardiovascular disease. Semin. Integr. Med. 2:23-35.
8. Srivastava KC, Bordia A, Verma SK. 1995. Curcumin, a major component of food spice turmeric (curcuma longa) inhibits aggregation and alters eicosanoid metabolism in human blood platelets. Prostaglandins Leukot. Essent. Fatty Acids 52:223-227.
9. Muthulakshmi V, Vijayakumar V, Vasanthkumar M, Vasanthi HR. 2009. Food is medicine and medicine is food: A siddha perspective. In: Functional Foods for Chronic Diseases, Vol. 4, edn. DM. Martirosyan, pp. 274-317. Richardson, TX: D & A Inc/FF Publishing.
10. Aggarwal BB, Van Kuiken ME, Iyer LH, Harikumar KB, Sung B. 2009. Molecular targets of nutraceuticals derived from dietary spices: Potential role in suppression of inflammation and tumorigenesis. Exp. Biol. Med. (Maywood) 234:825-849.
11. Nakayama R, Tamura Y, Yamanaka H, Kikuzaki H, Nakatani N. 1993. Curcuminoid pigments from Curcuma domestica. Phytochemistry 33:501-502.
12. Ohshiro M, Kuroyanagi M, Ueno A. 1990. Structures of sesquiterpenes from Curcuma longa. Phytochemistry 29:2201-2205.
13. Ravindranath V, Satyanarayana MN. 1980. An unsymmetrical diarylheptanoid from Curcuma longa. Phytochemistry 19:2031-2032.
14. Masuda T, Hidaka K, Shinohara A, Maekawa T, Takeda Y, Yamaguchi H. 1999. Chemical studies on antioxidant mechanism of curcuminoid: Analysis of radical reaction products from curcumin. J. Agric. Food Chem. 47:71-77.
15. Chan MM. 1995. Inhibition of tumor necrosis factor by curcumin, a phytochemical. Biochem. Pharmacol. 49:1551-1556.
16. Singh S, Aggarwal BB. 1995. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. J. Biol. Chem. 270:24995-25000.
17. Aggarwal BB, Shishodia S, Sandur SK, Pandey MK, Sethi G. 2006. Inflammation and cancer: How hot is the link? Biochem. Pharmacol. 72:1605-1621.
18. Wang SL, Li Y, Wen Y et al. 2009. Curcumin, a potential inhibitor of up-regulation of TNF-alpha and IL-6 induced by palmitate in 3T3-L1 adipocytes through NF-kappaB and JNK pathway. Biomed. Environ. Sci. 22:32-39.
19. Woo HM, Kang JH, Kawada T, Yoo H, Sung MK, Yu R. 2007. Active spice-derived components can inhibit inflammatory responses of adipose tissue in obesity by suppressing inflammatory actions of macrophages and release of monocyte chemoattractant protein-1 from adipocytes. Life Sci. 80:926-931.
20. Pendurthi UR, Rao LV. 2000. Suppression of transcription factor Egr-1 by curcumin. Thromb. Res. 97:179-189.
21. Xu J, Fu Y, Chen A. 2003. Activation of peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth. Am. J. Physiol. Gastrointest. Liver Physiol 285:G20-G30.
22. Jaiswal AS, Marlow BP, Gupta N, Narayan S. 2002. Beta-catenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells. Oncogene 21:8414-8427.
23. Ryu MJ, Cho M, Song JY et al. 2008. Natural derivatives of curcumin attenuate the Wnt/beta-catenin pathway through down-regulation of the transcriptional coactivator p300.Biochem. Biophys. Res. Commun. 377:1304-1308.
24. Bustanji Y, Taha MO, Almasri IM, Al-Ghussein MA, Mohammad MK, Alkhatib HS. 2008. Inhibition of glycogen synthase kinase by curcumin: Investigation by simulated molecular docking and subsequent in vitro/in vivo evaluation. J. Enzyme Inhib. Med. Chem. 24:771-778.
25. Andreadi CK, Howells LM, Atherfold PA, Manson MM. 2006. Involvement of Nrf2, p38, B-Raf, and nuclear factor-kappaB, but not phosphatidylinositol 3-kinase, in induction of hemeoxygenase-1 by dietary polyphenols. Mol. Pharmacol. 69:1033-1040.
26. Motterlini R, Foresti R, Bassi R, Green CJ. 2000. Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic. Biol. Med. 28:1303-1312.
27. Xia Y, Jin L, Zhang B, Xue H, Li Q, Xu Y. 2007. The potentiation of curcumin on insulin-like growth factor-1 action in MCF-7 human breast carcinoma cells. Life Sci. 80:2161-2169.
28. Tang Y, Zheng S, Chen A. 2009. Curcumin eliminates leptin’s effects on hepatic stellate cell activation via interrupting leptin signaling. Endocrinology 150:3011-3020.
29. Weisberg SP, Leibel R, Tortoriello DV. 2008. Dietary curcumin significantly improves obesity associated inflammation and diabetes in mouse models of diabesity. Endocrinology 149:3549-3558.
30. Srinivasan M. 1972. Effect of curcumin on blood sugar as seen in a diabetic subject. Indian J. Med. Sci. 26:269-270.
31. Srinivasan SR, Berenson GS, Radhakrishnamurthy B. 1970. Glycoprotein changes in diabetic kidneys. Diabetes 19:171-175.
32. Ramirez Bosca A, Soler A, Carrion-Gutierrez MA et al. 2000. An hydroalcoholic extract of Curcuma longa lowers the abnormally high values of human-plasma fibrinogen. Mech. Ageing Dev. 114:207-210.
33. Ramirez-Bosca A, Soler A, Carrion MA et al. 2000. An hydroalcoholic extract of Curcuma longa lowers the apo B/apo A ratio. Implications for atherogenesis prevention. Mech. Ageing Dev. 119:41-47.
34. Suri A, Szallasi A. 2008. The emerging role of TRPV1 in diabetes and obesity. Trends Pharmacol. Sci. 29:29-36.
35. Bhutani M, Pathak AK, Nair AS et al. 2007. Capsaicin is a novel blocker of constitutive and interleukin-6-inducible STAT3 activation. Clin. Cancer Res. 13:3024-3032.
36. Singh S, Natarajan K, Aggarwal BB. 1996. Capsaicin (8-methyl-N-vanillyl-6-nonenamide) is a potent inhibitor of nuclear transcription factor-kappa B activation by diverse agents. J. Immunol. 157:4412-4420.
37. Hsu CL, Yen GC. 2007. Effects of capsaicin on induction of apoptosis and inhibition of adipogenesis in 3T3-L1 cells. J. Agric. Food Chem. 55:1730-1736.
38. Kang JH, Kim CS, Han IS, Kawada T, Yu R. 2007. Capsaicin, a spicy component of hot peppers, modulates adipokine gene expression and protein release from obese-mouse adipose tissues and isolated adipocytes, and suppresses the inflammatory responses of adipose tissue macrophages. FEBS Lett. 581:4389-4396.
39. Cui J, Himms-Hagen J. 1992. Rapid but transient atrophy of brown adipose tissue in capsaicin-desensitized rats. Am. J. Physiol 262:R562-R567.
40. Zhang LL, Yan Liu D, Ma LQ et al. 2007. Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity. Circ. Res. 100:1063-1070.
41. Motter AL, Ahern GP. 2008. TRPV1-null mice are protected from diet-induced obesity. FEBS Lett. 582:2257-2262.
42. Belza A, Frandsen E, Kondrup J. 2007. Body fat loss achieved by stimulation of thermogenesis by a combination of bioactive food ingredients: A placebo-controlled, double-blind 8-week intervention in obese subjects. Int. J. Obes. (Lond.). 31:121-130.
43. Snitker S, Fujishima Y, Shen H et al. 2009. Effects of novel capsinoid treatment on fatness and energy metabolism in humans: Possible pharmacogenetic implications. Am. J. Clin. Nutr. 89:45-50.
44. Kadnur SV, Goyal RK. 2005. Beneficial effects of Zingiber officinale Roscoe on fructose induced hyperlipidemia and hyperinsulinemia in rats. Indian J. Exp. Biol. 43:1161-1164.
45. Sekiya K, Ohtani A, Kusano S. 2004. Enhancement of insulin sensitivity in adipocytes by ginger. Biofactors 22:153-156.
46. Gulcin I, Beydemir S, Hisar O. 2005. Effect of alpha-tocopherol on antioxidant enzyme activities and lipid peroxidation in rainbow trout (Oncorhynchus mykiss). Acta Vet. Hung. 53:425-433.
47. Srinivasan K. 2007. Black pepper and its pungent principle-Piperine: A review of diverse physiological effects. Crit. Rev. Food Sci. Nutr. 47:735-748.
48. Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. 1998. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 64:353-356.
49. Rauscher FM, Sanders RA, Watkins JB 3rd. 2000. Effects of piperine on antioxidant pathways in tissues from normal and streptozotocin-induced diabetic rats. J. Biochem. Mol. Toxicol. 14:329-334.
50. Crawford P. 2009. Effectiveness of cinnamon for lowering hemoglobin A1C in patients with type 2 diabetes: A randomized, controlled trial. J. Am. Board Fam. Med. 22:507-512.
51. Dugoua JJ, Seely D, Perri D et al. 2007. From type 2 diabetes to antioxidant activity: A systematic review of the safety and efficacy of common and cassia cinnamon bark. Can. J. Physiol. Pharmacol. 85:837-847.
52. Hlebowicz J, Darwiche G, Bjorgell O, Almer LO. 2007. Effect of cinnamon on postprandial blood glucose, gastric emptying, and satiety in healthy subjects. Am. J. Clin. Nutr. 85:1552-1556.
53. Jitomir J, Willoughby DS. 2009. Cassia cinnamon for the attenuation of glucose intolerance and insulin resistance resulting from sleep loss. J. Med. Food. 12:467-472.
54. Khan A, Safdar M, Ali Khan MM, Khattak KN, Anderson RA. 2003. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care 26:3215-3218.
55. Mang B, Wolters M, Schmitt B et al. 2006. Effects of a cinnamon extract on plasma glucose, HbA, and serum lipids in diabetes mellitus type 2. Eur. J. Clin. Invest. 36:340-341.
56. Roussel AM, Hininger I, Benaraba R, Ziegenfuss TN, Anderson RA. 2009. Antioxidant effects of a cinnamon extract in people with impaired fasting glucose that are overweight or obese. J. Am. Coll. Nutr. 28:16-21.
57. Saraswat M, Reddy PY, Muthenna P, Reddy GB. 2009. Prevention of nonenzymic glycation of proteins by dietary agents: Prospects for alleviating diabetic complications. Br. J. Nutr. 101:1714-1721.
58. Solomon TP, Blannin AK. 2007. Effects of short-term cinnamon ingestion on in vivo glucose tolerance. Diabetes Obes. Metab. 9:895-901.
59. Solomon TP, Blannin AK. 2009. Changes in glucose tolerance and insulin sensitivity following 2 weeks of daily cinnamon ingestion in healthy humans. Eur. J. Appl. Physiol. 105:969-976.
60. Ziegenfuss TN, Hofheins JE, Mendel RW, Landis J, Anderson RA. 2006. Effects of a water-soluble cinnamon extract on body composition and features of the metabolic syndrome in prediabetic men and women. J. Int. Soc. Sports Nutr. 3:45-53.
61. Anderson RA, Broadhurst CL, Polansky MM et al. 2004. Isolation and characterization of polyphenol type-A polymers from cinnamon with insulin-like biological activity. J. Agric. Food Chem. 52:65-70.
62. Jia Q, Liu X, Wu X et al. 2009. Hypoglycemic activity of a polyphenolic oligomer-rich extract of Cinnamomum parthenoxylon bark in normal and streptozotocin-induced diabetic rats. Phytomedicine 16:744-750.
63. Onderoglu S, Sozer S, Erbil KM, Ortac R, Lermioglu F. 1999. The evaluation of long-term effects of cinnamon bark and olive leaf on toxicity induced by streptozotocin administration to rats. J. Pharm. Pharmacol. 51:1305-1312.
64. Subash Babu P, Prabuseenivasan S, Ignacimuthu S. 2007. Cinnamaldehyde-A potential antidiabetic agent. Phytomedicine 14:15-22.
65. Verspohl EJ, Bauer K, Neddermann E. 2005. Antidiabetic effect of Cinnamomum cassia and Cinnamomum zeylanicum in vivo and in vitro. Phytother. Res. 19:203-206.
66. Kim SH, Hyun SH, Choung SY. 2006. Anti-diabetic effect of cinnamon extract on blood glucose in db/db mice. J. Ethnopharmacol. 104:119-123.
67. Sheng X, Zhang Y, Gong Z, Huang C, Zang YQ. 2008. Improved insulin resistance and lipid metabolism by cinnamon extract through activation of peroxisome proliferator-activated receptors. PPAR Res 2008:541348.
68. Qin B, Dawson H, Polansky MM, Anderson RA. 2009. Cinnamon extract attenuates TNF-alphainduced intestinal lipoprotein ApoB48 overproduction by regulating inflammatory, insulin, and lipoprotein pathways in enterocytes. Horm. Metab. Res. 41:516-522.
69. Imparl-Radosevich J, Deas S, Polansky MM et al. 1998. Regulation of PTP-1 and insulin receptor kinase by fractions from cinnamon: Implications for cinnamon regulation of insulin signaling. Horm. Res. 50:177-182.
70. Cao H, Polansky MM, Anderson RA. 2007. Cinnamon extract and polyphenols affect the expression of tristetraprolin, insulin receptor, and glucose transporter 4 in mouse 3T3-L1 adipocytes. Arch. Biochem. Biophys. 459:214-222.
71. Peng X, Cheng KW, Ma J et al. 2008. Cinnamon bark proanthocyanidins as reactive carbonyl scavengers to prevent the formation of advanced glycation endproducts. J. Agric. Food Chem. 56:1907-1911.
72. Vijayakumar MV, Pandey V, Mishra GC, Bhat MK. 2010. Hypolipidemic effect of fenugreek seeds is mediated through inhibition of fat accumulation and upregulation of LDL receptor. Obesity (Silver Spring). 18:667-674.
73. Kawada T, Hagihara K, Iwai K. 1986. Effects of capsaicin on lipid metabolism in rats fed a high fat diet. J. Nutr. 116:1272-1278.
74. Sharma RD, Rukmini C.1986. Rice bran oil and hypocholesterolemia in rats. Lipids 21:715-717.
75. Srinivasan K, Patole PS, Kaul CL, Ramarao P. 2004. Reversal of glucose intolerance by pioglitazone in high fat diet-fed rats. Methods Find. Exp. Clin. Pharmacol. 26:327-333.
76. Asai A, Nakagawa K, Miyazawa T. 1999. Antioxidative effects of turmeric, rosemary and capsicum extracts on membrane phospholipid peroxidation and liver lipid metabolism in mice. Biosci. Biotechnol. Biochem. 63:2118-2122.
77. Naidu KA, Thippeswamy NB. 2002. Inhibition of human low density lipoprotein oxidation by active principles from spices. Mol. Cell Biochem. 229:19-23.
78. Reddy AC, Lokesh BR. 1994. Studies on the inhibitory effects of curcumin and eugenol on the formation of reactive oxygen species and the oxidation of ferrous iron. Mol. Cell Biochem. 137:1-8.
79. Manjunatha H, Srinivasan K. 2006. Protective effect of dietary curcumin and capsaicin on induced oxidation of low-density lipoprotein, iron-induced hepatotoxicity and carrageenan-induced inflammation in experimental rats. FEBS J. 273:4528-4537.
80. Agbor GA, Oben JE, Ngogang JY, Xinxing C, Vinson JA. 2005. Antioxidant capacity of some herbs/spices from Cameroon: A comparative study of two methods. J. Agric. Food Chem. 53:6819-6824.
81. Shan B, Cai YZ, Sun M, Corke H. 2005. Antioxidant capacity of 26 spice extracts and characterization of their phenolic constituents. J. Agric. Food Chem. 53:7749-7759.
82. Raghavendra RH, Naidu KA. 2009. Spice active principles as the inhibitors of human platelet aggregation and thromboxane biosynthesis. Prostaglandins Leukot. Essent. Fatty Acids. 81:73-78.
83. Prasad NS, Raghavendra R, Lokesh BR, Naidu KA. 2004. Spice phenolics inhibit human PMNL 5-lipoxygenase. Prostaglandins Leukot. Essent. Fatty Acids 70:521-528.
84. Fogelman AM, Shechter I, Seager J, Hokom M, Child JS, Edwards PA. 1980. Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages. Proc. Natl. Acad. Sci. USA 77:2214-2218.
85. Haberland ME, Fong D, Cheng L. 1988. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science 241:215-218.
86. Palinski W, Rosenfeld ME, Yla-Herttuala S et al. 1989. Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. USA 86:1372-1376.
87. Yla-Herttuala S, Palinski W, Rosenfeld ME et al. 1989. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84:1086-1095.
88. Marnett LJ. 1999. Lipid peroxidation-DNA damage by malondialdehyde. Mutat. Res. 424:83-95.
89. Gorelik S, Ligumsky M, Kohen R, Kanner J. 2008. The stomach as a “bioreactor”: When red meat meets red wine. J. Agric. Food Chem. 56:5002-5007.
90. Gorelik S, Ligumsky M, Kohen R, Kanner J. 2008. A novel function of red wine polyphenols in humans: Prevention of absorption of cytotoxic lipid peroxidation products. FASEB J. 22:41-46.
91. Gorelik S, Lapidot T, Shaham I et al. 2005. Lipid peroxidation and coupled vitamin oxidation in simulated and human gastric fluid inhibited by dietary polyphenols: Health implications. J. Agric. Food Chem. 53:3397-3402.
92. Gorelik S, Kohen R, Ligumsky M, Kanner J. 2007. Saliva plays a dual role in oxidation process in stomach medium. Arch. Biochem. Biophys. 458:236-243.
93. Li Z, Henning SM, Zhang Y et al. 2010. Antioxidant-rich spice added to hamburger meat during cooking results in reduced meat, plasma, and urine malondialdehyde concentrations. Am. J. Clin. Nutr. 91:1180-1184.
94. Brower V. 1998. Nutraceuticals: Poised for a healthy slice of the healthcare market? Nat Biotechnol. 16:728-731.
95. Zeisel SH. 1999. Regulation of “nutraceuticals”. Science 285:1853-1855.